GNC files motion to remove OR AG’s lawsuit to Federal Court

By Stephen DANIELLS

- Last updated on GMT

GNC files motion to remove OR AG’s lawsuit to Federal Court

Related tags: Gnc

Supplement retailing giant GNC Holdings, Inc. has filed a motion to remove to Federal Court the lawsuit filed against it by Oregon Attorney General Ellen Rosenblum.

AG Rosenblum cited GNC for the sale of dietary supplements alleged to contain illegal dietary ingredients, specifically picamilon and BMPEA, alternately listed as Acacia rigidula​. The suit seeks significant penalties for what the OR AG alleges is violation of that state’s consumer protection statutes.

Sales for GNC were trading at around $39.50 before the OR AG announced her actions​. Share prices subsequently fell by almost 15% but have since recovered somewhat and were at $37.01 at the close of trading on Monday, Oct 26.  

Michael Mulè, a partner at Rivkin Radler LLP, explained that filing a motion to remove to Federal Court is a standard tactic and is a very simple procedure.

“There are two bases for removal,” ​he told us. “The first is that the underlying lawsuit involves a federal question, and the second is diversity, meaning that the defendants are incorporated or headquartered in another state to the plaintiffs.”

‘FDA nor any court has issued a legally binding determination of the status of these ingredients’

In addition to filing for removal, the retailer also issued the following statement, which we have reproduced in full: 

“GNC believes that the lawsuit filed by the Oregon Attorney General is without merit, and the Company intends to defend itself vigorously against this unfair action.

“Regrettably, despite our best efforts, we were unable to reach an agreement with the Oregon Attorney General.  As a next step, the Company filed today to have the action moved to Federal court.  Products sold by GNC are regulated by the U.S. Food and Drug Administration. GNC's vendors certify that they are in full compliance with the Food, Drug and Cosmetic Act (FDC Act), and to guarantee that their products meet all applicable Federal and state laws.

“Consistent with retail standard practice, GNC has appropriately relied on the guarantees of suppliers that their products are lawful.   This is a basic tenet of retail sales and is recognized in federal law in the FDC Act and what is known nationally as the ‘FDA Guarantee’. GNC is contractually entitled to indemnification by its third-party vendors related to these guarantees and requires appropriate levels of third party vendor insurance.

“GNC takes the quality of its products and compliance by third parties seriously, and the Company takes responsible measures to review any concerns when raised by the FDA or other regulatory bodies.  With respect to the two ingredients at issue in the Oregon Attorney General's lawsuit, picamilon was included as an ingredient in dietary supplements widely sold by major retailers up to the time of the filing of Oregon's lawsuit on October 22, 2015, and products containing BMPEA were also widely available until the FDA issued a warning letter in April, 2015. There is no basis for the Oregon Attorney General's assertion that GNC or any other retailer ‘knew or should have known’ that these ingredients were not legal for use in dietary supplements. As a matter of law, this critical legal issue remains undetermined as neither FDA nor any court has issued a legally binding determination of the status of these ingredients.

“GNC stopped selling products with BMPEA and picamilon, immediately upon learning indirectly, rather than from notice directed at GNC, that FDA did not view BMPEA and picamilon as legal dietary ingredients. Neither picamilon nor BMPEA were included in a previous FDA warning letter or other FDA notification. Further, GNC took action to remove BMPEA and picamilon products even though the FDA did not raise any safety concerns with respect to these ingredients, and neither notice constituted a legally binding FDA action on the legal status of these ingredients. Products containing BMPEA and picamilon were produced by third parties and accounted for less than one percent of the Company's sales.

“GNC will continue to play a leading role in setting industry quality and compliance standards, as we always have. We are committed to providing our customers with the highest quality supplements available, using the purest and most effective ingredients, to help them live healthier lives.”

Related topics: Manufacturers

Related news

Show more

Follow us

Featured Events

View more

Products

View more

Webinars